Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 06 Mar 2023
In a new study, researchers report the use of inhaled corticosteroids (HFNC) in patients with mild to moderate bronchiolitis...
Read Full NewsThe U.S. FDA issued a warning letter to medical device maker Medline over violations of manufacturing quality standards, the second such action against the company in two...
An intramuscular Masson tumor in the deltoid muscle mimics a malignant vascular tumor on imaging, making surgical excision and histopathologic diagnosis essential.
Ethicist Art Caplan discusses the ethics of healthcare strikes for patients and workers.
Cardiologist Chris Labos takes a look at the French paradox and the J-shaped curve — which tout moderate alcohol as healthy — and asks is the amount of alcohol you should drink really zero?
Drs Ursula A. Matulonis and Stephanie Lheureux discuss the importance of investigator-initiated clinical trials in endometrial cancer, research on carcinosarcoma, and ctDNA.
A skin-mounted ultrasound patch tracks fetal blood flow in real time and may help detect complications in high-risk pregnancies earlier than intermittent scans.
An experimental treatment for spinal cord injuries is drawing patients from as far as Mexico, mobilizing the government to expedite approval before its safety has been proven in a clinical trial.
1.
A US health panel advises starting mammograms at age 40 rather than 50.
2.
The most precise research tools for the deadliest blood cancer have been developed.
3.
Promising OS at 5 Years With Chemo-Free Combo in Urothelial Cancer
4.
The FDA approves Enhertu for HER2-positive cancers, regardless of tumor type.
5.
Upfront TKI for Bone-Predominant RCC Tops Single-Agent Immunotherapy
1.
Omitting Axillary Dissection in Node-Positive Breast Cancer: Insights from the SENOMAC Trial
2.
A New Hope: Exploring the Benefits of Exenteration for Cancer Patients
3.
The Statistical Frontier of Hematology Oncology: Diagnostics, Therapies, and Future Horizons in Hematology Oncology 2025
4.
Managing KRAS Inhibitor Toxicities: Focus on Rash and Beyond
5.
ERASur: Evaluating Total Ablative Therapy in Limited Metastatic Colorectal Cancer
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment
2.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
3.
The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
4.
Learning About Different Treatment Approaches For Acute Lymphoblastic Leukemia
5.
Efficient Management of First line ALK-rearranged NSCLC
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge